The award recognizes multigenerational, family-owned, as well as closely held businesses in the Triangle for overall excellence, innovation, ethics, philanthropy and contribution to the strength of the region.
Chapel Hill, NC ̶ December 11, 2017 ̶ Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, has been named a winner of the 2017 Family Business Award by the Triangle Business Journal, a multimedia source for local business news, research and events in the Raleigh, Durham and Chapel Hill region of North Carolina, where Rho is headquartered.
The award recognizes multigenerational, family-owned, as well as closely held businesses in the Triangle for overall excellence, innovation, ethics, philanthropy and contribution to the strength of the region. Additionally, these awards showcase the entrepreneurial spirit and dynamic vitality of the family businesses sector – one that employs thousands of people in this area.
“It is an honor to be named a 2017 Family Business Award winner by Triangle Business Journal. Rho would not exist if not for the vision and sacrifice my parents made,” said Laura Helms Reece, chief executive officer for Rho. “For more than 33 years, Rho has been committed to conducting its business in the Triangle region where the company first started, contributing to the local economy and supporting our community, which we love.”
Rho is one of 16 winners that was recently honored at an awards dinner on Dec. 7 at Prestonwood Country Club in Cary, North Carolina.
To learn more about Rho, please visit www.rhoworld.com.
About Rho
Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For more than 33 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. Please follow us on Twitter.
